| Financial Year |
March 31 2023 |
| Monetary Funds |
235,053,280.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,824,031.79 |
| Accounts Receivable |
796,678,049.27 |
| Advances to Suppliers |
117,731,592.27 |
| Other Receivables |
68,094,281.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
994,024.93 |
| Dividend Receivable |
-- |
| Inventories |
110,095,131.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,439,780.30 |
| Other Current Assets |
36,308,382.14 |
| Total Current Assets |
1,567,337,977.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
230,612,847.96 |
| Long-term Equity Investment |
13,155,360.69 |
| Investment Properties |
96,663.12 |
| Fixed Assetes |
28,311,358.14 |
| Under-construction Projects |
216,981.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,256,948.23 |
| R&D expenses |
-- |
| Goodwill |
23,115,186.16 |
| Long-Term Deferred and Prepaid Expenses |
259,065.14 |
| Deferred Income Tax Assets |
70,607,984.39 |
| Other Non-Current Assets |
100,803,478.05 |
| Sub-Total of Non-Current Assets |
553,745,760.78 |
| Total Assets |
2,121,083,738.38 |
| Short-Term Loans |
155,044,837.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
165,134,856.95 |
| Accounts Payable |
739,332,932.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,842,491.83 |
| Taxes Payable |
92,428,505.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,063,660.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
152,870,622.87 |
| Other Current Liabilities |
22,069,513.59 |
| Sub-Total of Current Liabilities |
1,611,605,034.76 |
| Long-term Loans |
193,668,420.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,424,751.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
214,911,198.15 |
| Total Liabilities |
1,826,516,232.91 |
| Paid-In Capital(Or Share Stock) |
157,719,000.00 |
| Capital Surplus |
172,862,437.45 |
| Surplus Reserve |
17,050,278.88 |
| LESS:Treasury Stock |
8,914,883.63 |
| Undistributed Profits |
-131,546,395.56 |
| Minority Stockholder's Interest |
87,397,068.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
207,170,437.14 |
| Owner's Equity（Stockholder's Equity） |
294,567,505.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,121,083,738.38 |
